? LEADERSHIP, PLANNING AND EVALUATION As a NCI Comprehensive Cancer Center, Duke Cancer Institute?s Senior Leadership is the central decision- making, institutional advisory body and is organized as a diverse and representative group that prioritizes and promotes research productivity, investments, recruitment, endorses interaction and collaboration, takes maximum advantage of institutional strengths, assures community involvement and fosters unique scientific opportunities through a robust committee structure. These activities are delineated in the DCI overall and disease specific strategic plans. The Executive Director actively seeks and fosters the opinions, feedback, guidance and advice from Senior Leadership, who have expertise in operational and scientific leadership to plan and execute priorities and initiatives. Strong guidance, vision and advice is provided by a senior group of external counselors (External Scientific Advisory Committee; Executives and Chairs from School of Medicine and Duke University Health System). All counselors are an integrated part of DCI?s planning process. Strategic planning and evaluation have been critical for the current systems reviews and future development of DCI. Ongoing planning, evaluation and guidance in all areas, are a major responsibility for the committees discussed and are essential to maintaining a steep scientific and operational excellence (performance driven, strategic and systematic processes) trajectory. Rigorous planning and evaluation is carried out on an ongoing basis through multiple internal and external mechanisms in all divisions of DCI. The DCI?s Executive Director synchronizes and has broad authority across leadership, strategic planning, clinical, evaluation, scientific, budgetary, outreach and administrative matters for the center. These priorities, investments and initiatives are codified in the DCI strategic plan.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Abdi, Khadar; Lai, Chun-Hsiang; Paez-Gonzalez, Patricia et al. (2018) Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus. Nat Commun 9:1655
Hudson, Kathryn E; Rizzieri, David; Thomas, Samantha M et al. (2018) Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study. Br J Haematol :
Fayanju, Oluwadamilola M; Park, Ko Un; Lucci, Anthony (2018) Molecular Genomic Testing for Breast Cancer: Utility for Surgeons. Ann Surg Oncol 25:512-519
Porter, Laura S; Fish, Laura; Steinhauser, Karen (2018) Themes Addressed by Couples With Advanced Cancer During a Communication Skills Training Intervention. J Pain Symptom Manage 56:252-258
Káradóttir, Ragnhildur T; Kuo, Chay T (2018) Neuronal Activity-Dependent Control of Postnatal Neurogenesis and Gliogenesis. Annu Rev Neurosci 41:139-161
Han, Peng; Liu, Hongliang; Shi, Qiong et al. (2018) Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck. Mol Carcinog 57:784-793
Xu, Yinghui; Wang, Yanru; Liu, Hongliang et al. (2018) Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog 57:22-31
Abdi, Khadar; Kuo, Chay T (2018) Laminating the mammalian cortex during development: cell polarity protein function and Hippo signaling. Genes Dev 32:740-741
Lu, Min; Sanderson, Sydney M; Zessin, Amelia et al. (2018) Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. Cancer Metab 6:14
Qian, Danwen; Liu, Hongliang; Wang, Xiaomeng et al. (2018) Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. Int J Cancer :

Showing the most recent 10 out of 513 publications